血清素-2A GPCR中的一个功能选择性机制涉及细胞内循环2的依赖联体的构造
Jose Manuel Perez-Aguilar1, Jufang Shan, Michael V LeVine
1Department of Physiology and Biophysics and §The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Medical College of Cornell University , New York, New York 10065, United States.
Journal of the American Chemical Society
|October 15, 2014
概括
分子动力学模拟显示,当与幻觉激素和非幻觉激素激剂结合时,胺2A受体 (5-HT(2A) R的结构变化明显. 这些差异,特别是在细胞内循环2中,可能解释功能选择性和不同的精神活性效应.
科学领域:
- 结构生物学 结构生物学
- 计算化学计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- G蛋白结合受体 (GPCRs) 是关键的药物标,了解它们的结构状态是药物开发的关键.
- 结构生物学和生物物理技术的最新进展允许GPCRs的详细表征.
- 分子动力学 (MD) 模拟提供了一种强大的计算方法来研究GPCRs中的动态构造变化.
研究的目的:
- 为了研究与不同激动剂结合时,人类血清素2A受体 (5-HT(2A) R) 的动态构造差异.
- 阐明5-HT(2A) R配体的功能选择性和不同药理结果 (幻觉性与非幻觉性) 的结构基础.
- 探索特定受体区域的作用,如细胞内循环2 (ICL2) 在调解依赖连接体激活中的作用.
主要方法:
- 进行了无偏见的微秒长度的全原子分子动力学 (MD) 模拟5-HT(2A) R.
- 模拟了受体在apo (无基) 状态和结合四种不同的血清激素激动剂,具有已知的独特的药理学特征.
- 分析模拟轨迹以确定差异性联结接触和构造变化.
主要成果:
- 在与幻觉性和非幻觉性联体相互作用时,确定了5-HT(2A) R中明显的结构和动态差异.
- 观察到与细胞内循环2 (ICL2) 独特形状相关的差异性联结接触.
- 这些ICL2构造变化被建议影响受体二分化和/或与效应蛋白的直接相互作用,这表明功能选择性的机制.
结论:
- 这项研究提供了证据,证明了5-HT(2A) R.中的联体特异形态异质性.
- 细胞内循环2 (ICL2) 成为一个关键区域,微调受体激活并区分功能结果.
- 这些发现提供了对幻觉产生和GPCR功能选择性背后的分子机制的见解.
相关概念视频
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
The Two-State Receptor Model
3.5K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.5K
Dose-Response Relationship: Selectivity and Specificity
10.1K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.1K
Transducer Mechanism: G Protein–Coupled Receptors
8.4K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
8.4K
Selectins
3.6K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.6K
G-protein Coupled Receptors
90.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
90.7K


